Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Inouye

Showing results (131-140 of 614) with videos related to

Pageof 62
Sort By:
Journal of Immunological Methods|December 5, 1990
The use of N-(aminobenzoyloxy) succinimide as a two-level heterobifunctional agent for the preparation of hapten-protein conjugates. Daunomycin as a model hapten with an amino groupK Fujiwara, N Matsumoto, T Kitagawa, et al.
JAMA Internal Medicine|March 24, 2025
Appropriate Deprescribing and Payment in Hospice Dementia CareNathan M Stall, Sharon K Inouye, Lona Mody
JAMA Internal Medicine|August 5, 2024
Why Do We (and Still Do!) Need the National Institute on Aging-50 Years of InnovationKenneth E Covinsky, Lona Mody, Sharon K Inouye
JAMA Internal Medicine|April 6, 2026
Insulin Copay Caps-Impacts Beyond CostsAnna Hung, Sharon K Inouye, Raegan W Durant
JAMA Network Open|June 16, 2021
Enhancing Aging and Ending Ageism: JAMA Network Open Call for PapersSharon K Inouye, Ishani Ganguli, Elizabeth A Jacobs
Journal of the Neurological Sciences|July 1, 1986
"Ragged-red" fibres in myotonic dystrophyS Ono, H Kurisaki, K Inouye, et al.
FEBS Letters|November 7, 2001
Involvement of B-Raf in Ras-induced Raf-1 activationS Mizutani, K Inouye, H Koide, et al.
Journal of the American Geriatrics Society|November 19, 2016
The Search for Effective Delirium Treatment for Persons with Dementia in the Postacute-Care SettingTamara G Fong, Asha Albuquerque, Sharon K Inouye
Drug Design and Delivery|January 1, 1989
Buoyant sustained release granules based on chitosanK Inouye, Y Machida, T Sannan, et al.
Drug Design and Delivery|February 1, 1988
Buoyant sustained release tablets based on chitosanK Inouye, Y Machida, T Sannan, et al.
Pageof 62

Showing results (131-140 of 614) with videos related to

Sort By:
Pageof 62
Journal of Immunological Methods|December 5, 1990
The use of N-(aminobenzoyloxy) succinimide as a two-level heterobifunctional agent for the preparation of hapten-protein conjugates. Daunomycin as a model hapten with an amino groupK Fujiwara, N Matsumoto, T Kitagawa, et al.
JAMA Internal Medicine|March 24, 2025
Appropriate Deprescribing and Payment in Hospice Dementia CareNathan M Stall, Sharon K Inouye, Lona Mody
JAMA Internal Medicine|August 5, 2024
Why Do We (and Still Do!) Need the National Institute on Aging-50 Years of InnovationKenneth E Covinsky, Lona Mody, Sharon K Inouye
JAMA Internal Medicine|April 6, 2026
Insulin Copay Caps-Impacts Beyond CostsAnna Hung, Sharon K Inouye, Raegan W Durant
JAMA Network Open|June 16, 2021
Enhancing Aging and Ending Ageism: JAMA Network Open Call for PapersSharon K Inouye, Ishani Ganguli, Elizabeth A Jacobs
Journal of the Neurological Sciences|July 1, 1986
"Ragged-red" fibres in myotonic dystrophyS Ono, H Kurisaki, K Inouye, et al.
FEBS Letters|November 7, 2001
Involvement of B-Raf in Ras-induced Raf-1 activationS Mizutani, K Inouye, H Koide, et al.
Journal of the American Geriatrics Society|November 19, 2016
The Search for Effective Delirium Treatment for Persons with Dementia in the Postacute-Care SettingTamara G Fong, Asha Albuquerque, Sharon K Inouye
Drug Design and Delivery|January 1, 1989
Buoyant sustained release granules based on chitosanK Inouye, Y Machida, T Sannan, et al.
Drug Design and Delivery|February 1, 1988
Buoyant sustained release tablets based on chitosanK Inouye, Y Machida, T Sannan, et al.
Pageof 62